In This Issue
- Introduction by Robert Kyle, MD - It is an honor and a pleasure to provide an introductory note to this issue of Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC)'s "Advances in Hematologic Malignancies," with a focus on multiple myeloma.
- Complex Case Study: Multiple Myeloma with Secondary Light Chain Amyloidosis - A 59-year-old woman presented with three months of fatigue and severe joint pain involving the elbows, wrists, knees, and ankles, as well as anemia. She underwent a total of four diagnostic arthrocenteses, though the specific underlying cause of joint pain remained unknown.
- New DF/BWCC Program Physician in Waldenström's Macroglobulinemia - The Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) Bing Center for Waldenström's Macroglobulinemia is pleased to welcome Jorge Castillo, MD, as program physician.
- Patient Care Spotlight: Current Management of Hypercalcemia Associated with Multiple Myeloma - Patients with multiple myeloma are commonly diagnosed with hypercalcemia.
- Research Spotlight: Bench to Bedside Translation of Targeted Therapeutics in Multiple Myeloma - Multiple myeloma (MM) is a remarkable contemporary example of rapid bench-to-bedside translation in new drug development.
Additional Resources
Hematologic Oncology Treatment Center
Clinical Trials for Hematologic Malignancies
Older Adult Hematologic Malignancy Program